Funded Data and Analytics Startups in Houston
Across these 11 Houston-based data and analytics entries, the largest disclosed round is ComboCurve’s $50M on 2022-04-12, which dwarfs the next-largest dis…
Across these 11 Houston-based data and analytics entries, the largest disclosed round is ComboCurve’s $50M on 2022-04-12, which dwarfs the next-largest disclosed amounts of $33M (GoExpedi, 2022-11-23) and $18M (Graylog, 2021-06-24). Disclosed amounts largely cluster between $1M and $13M (e.g., Elevate Clinical Research $1M on 2026-02-17; SynMax $13M on 2024-01-08), while most higher figures are concentrated in earlier years.
The list shows a temporal concentration and a disclosure mix. Three disclosed rounds fall in 2022 (ComboCurve on 2022-04-12, GoExpedi on 2022-11-23, Kinetic Pressure Control on 2023-06-13 is nearby but not 2022), and the overall date span runs from 2021-06-24 (Graylog) through 2026-06-25 (Quaise Energy). Stage labeling is split: 4 of 11 entries are “Series Unknown” and 3 of 11 are “undisclosed” by amount, leaving fewer rows with explicit dollar figures. All rows are located in Houston, Texas, United States in this view.
Most recent rounds
11 shownRelated listings
Frequently asked
Which disclosed round is an outlier, and what does it look like versus other disclosed amounts in Houston data/analytics?
ComboCurve’s $50M round on 2022-04-12 is the top disclosed amount in the table and sits far above the next-largest disclosed rounds: GoExpedi at $33M (2022-11-23) and Graylog at $18M (2021-06-24). Most other disclosed figures fall at or below $13M, including SynMax’s $13M on 2024-01-08 and Elevate Clinical Research’s $1M on 2026-02-17.
How much of the recent activity clusters near the end of the date window (most recent 90 days) in this Houston list?
In the most recent 90-day slice relative to the latest entry (2026-06-25), there are two dated rounds: Quaise Energy on 2026-06-25 (amount undisclosed) and Elevate Clinical Research on 2026-02-17 ($1M). Bardasz’s 2026-02-12 round is also in the same recent half-year window but is listed with an undisclosed amount.
Is the stage mix skewed toward specific labels, given the disclosure patterns here?
Across 11 rows, “Series Unknown” appears 4 times (Quaise Energy 2026-06-25; Bardasz 2026-02-12; Getech Group 2024-08-08; The Sterling Group 2023-08-09). Seed appears 2 times (Elevate Clinical Research 2026-02-17 with $1M; SynMax 2024-01-08 with $13M), while “Series B” appears once (ComboCurve, 2022-04-12, $50M). Three rows are marked with an undisclosed amount (Quaise Energy, Bardasz, The Sterling Group).
Do disclosed amounts concentrate in a narrow range, or is spread driven by a few high-end events?
The disclosed amounts show a floor-to-midrange concentration: $1M (Elevate Clinical Research, 2026-02-17), $2M (Getech Group, 2024-08-08), $4M (Datagration, 2023-08-11), $5M (Kinetic Pressure Control, 2023-06-13), and $13M (SynMax, 2024-01-08) make up much of the non-undisclosed set. The higher disclosed end is driven by GoExpedi’s $33M (2022-11-23) and especially ComboCurve’s $50M (2022-04-12).
Are there any repeated city/geography signals, or is Houston consistently represented across entries shown?
Every row shown lists Houston, Texas, United States as the location, including Graylog (2021-06-24, $18M) and ComboCurve (2022-04-12, $50M). In this view, there are no alternate city variants; Houston is the consistent geographic key across all 11 entries.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.